Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy by Hasegawa, T et al.
! 
Orthotopic Liver Transplantation for Ornithine Transcarbamylase 
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• Ornithine transcarbamylase IOTCI deficiency is an X 
chromosome-linked disorder causing hyperammonemic en-
cephalopathy with a very poor prognosis. We describe here 
two patients with OTe deficiency. one a late-onset female 
patient lease 11 and the other a neonatal-onset male patient 
(case 2). who were successfully treated with orthotopic live, 
transplantation IOLTxl. The OTC activity in the excised liver 
was 10% and 0 % of control. respectively. Hyperammonemic 
encephalopathy was controlled with medical therepy in case 
1 until the age of 5 years. but the complicated course in case 2 
in which hyperammonemia required peritoneal dialysis and 
hemodialysis in the neonatal period necessitated OL Tx with 
a reduced-size liver at the age of 80 days. Both patients had 
restoration of serum ammonia level to normal in 2 and 3 days 
after liver replacement, and both patients have normal 
neurological and developmental status after 2 and 0.5 years 
of postoperative follow-up. These cases illustrate not only 
the metabolic cure of this disorder, but also the need to 
preserve neurological integrity by aggressive medical man-
agement of the hyperammonemia preoperatively and early 
surgical intervention when indicated. even if this is required 
very early in life. 
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ORNITHINE transcarbamylase (OTC) deficiency is an X chromosome-linked disorder that causes 
hyperammonemia and elevated blood glutamine lev-
clS. I-4 The acute development of these metabolic 
abnormalities causes brain edema. which often 
progresses to coma and death. I·" Patients with urea 
cycle enzyme abnormalities including OTC deficiency 
have undergone liver transplantation as a substitutive 
treatment for medical therapy.l.s.7.s This article de-
scribes two cases of OTC deficiency with hyperammo-
nemic encephalopathy that were successfully treated 
with orthotopic liver transplantation. 
CASE REPORTS 
Case J 
A girl wilh an uncomplicated gestallon and delivery presented 
wilh vomltang and feeding intolerance at aboul 3 weeks of age. Her 
ammonia h:vd was elevated to 337 ILmoi/L which could be 
controllc:d by protean restriction. At the age of I year. serum amano 
a~id analysis showed an elevated glutamine level. Despite treat-
ment with benzoate. citrulline. and carnnine. she experienced 
penodic episodes of hyperammonemlc encephalopathy rangmg 
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from lethargy to coma and was referred to our institution at the age 
of 5 years in July 1991. Her only presenting symptom was a mildly 
ataxic gait. Her ammonia level was 151 I-LmoltL. serum glutamine 
level was I08ILmoi/dL (control. 32 to 87I-Lmol/dL). She had a body 
weight of 26 kg. blood urea nitrogen less than 2mg/dL, and mildly 
elevated liver enzymes. 
On July 17. 1991. she underwent orthotopic liver transplantation 
from a 6-year-old donor of identical blood type and body weight. 
using a piggy-back method~ and Roux-en-Y choledochojejunos-
tomy. FK 506 (Tacrolimus: Fiujisawa Pharmaceutical Co. Osaka. 
Japan) and steroids were used as immunosuppressive agents. and 
the postoperative course was uneventful. From the resected native 
liver. OTC enzyme analysis showed a residual activity of about 10% 
(235 I-Lmol/h/g weight of liver: control. 2417 ILmolth/g weight of 
liver). Carbamyl phosphate synthetase I. arginosuccinate synthe-
tase. arginosuccinase. and arginase enzyme activities were within 
normal ranges. Plasma ammonia levels returned to a normal range 
on the second postoperative day. She has had no neurological 
deficits. and after a 2-year follow-up. she is doing well without 
protein restriction and has normal development. 
ease 2 
A boy with a full-term uncomplicated delivery manifested 
symptoms of lethargy and decreased breast fceding frequency at 
around 24 hours of age. By J6 hours. he hegan vomiting with 
concomitant respiratory alkaillsis and an elevated ammonia level of 
3341-LmollL. The serum glutamate level was elevated (28I-LmoildL; 
control. 0 to 10 ILmoildL) and citrulline was nondetectable. 
Urinary orolic acid was markedly elevated (173 IJ.moilmin creati-
nine: control. [) to 3 ILmolimin crealinine). From the liver biopsy 
performed at the age of 27 days. OTC enzyme a~tivity was 
completely nllndetectable. The other urea q'cle enzyme activities 
were normal. lie was placed on a low-prolem diet. benzoate. and 
phenylacetate_ Despite this therapy. epislIdic hyperammonemia 
developed. associated with severe lethargy. ,md peritoneal dialysis 
and hemodialysis were required. On October 2. 1993. he was 
Iransferred 10 our inslltution with an ammonia level of 130 
IJ.moilL. His liver enzyme levels were slightly elevated. He was 
profoundly lethargic but with nll fllcal neurological deficits. All 
olher systems wac within normal range. 
On October IS. 19tJ3. at the age of ISO days (hody weight 6 kg). he 
underwent orthotopic liver transplantation using a reduced-size 
lefllaterallobe liver graft from a 5-year-old 26 kg donor of identical 
hlood type_ The operation was performed using a piggy-back 
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melhod~ and Roux-en-Y choledochojejunostomy. Immunosuppres-
sion was with FK 506 and steroids. Except for intraabdominal 
bleeding necessitating reexploralion on day I and seizures on day 2 
(ammonia 69 I1moI/L). his recovery was steady. By the third 
postoperative day. the ammonia level as well as his serum amino 
acids and urinary orotic acid levels returned to normal. A mild 
acute cellular rejection was treated with increased steroids. and a 
pleural effusion resolved with total parenteral nutrition. On 
6·month follow-up. he has been well with no neurological or 
developmental impairment. 
DISCUSSION 
OTe deficiency is clinically classified into two 
groups, neonatal-onset male patients and late-onset 
female patients. We had one of each. Because the 
structural gene encoding for the OTe enzyme protein 
is located on the short arm of the X-chromosome, Xp 
21,I,2 the homozygous male patient typically is com-
pletely enzyme deficient and subsequently has en-
cephalopathy caused by hyperammonemia, which 
presents as irritability. poor feeding, vomiting. and leth-
argy. usually within the first week of life. 1.3.5.6 These 
neonatal-onset patients have poor prognoses. 1·3.5.6 
In contrast. the heterozygous female patient has a 
partial enzyme deficiency because of random inactiva-
tion of the X-chromosome caused by lyonization. 1.J•5 
These patients have variable clinical symptoms that 
manifest later in life. occurring after 1 month of age, 
or possibly not at aI1. 1 • .1.5 Our female patient (case 1) 
had partial enzyme deficiency with late-onset symp-
toms. whereas our male patient (case 2) completely 
lacked the OTC activity and consequently had acute 
onset of symptoms shortly after birth and required 
peritoneal dialysis and hemodialysis. despite which 
hyperammonemia was refractory to treatment. 
A serum ammonia level greater than 200 ILmol/ L 
causes diffuse brain edemaK~ With the rapid elevation 
of ammonia. irreversible brain edema and herniation 
develop. which invariably result in death without 
prompt intervention. l ·n The initial medical therapy 
consists of protein restriction. benzoate. phenylac-
I!tate. arginine. citrulline. pyridoxine. and folic acid 
administration. and peritoneal dialysis or hemodialy-
sisK1KOK~KR These therapies are burdensome and can 
have side etfects of developmental impairment second-
ary to malnutritionK~·R Moreover. despite medical 
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intervention, most of the patients have recurrent 
hyperammonemia, which is easily precipitated by 
catabolic stress. such as starvation, dehydration. surgi-
cal operation, and infection. 1.2.4.5 Both of our patients 
(especially case 2) were prone to hyperammonemic 
encephalopathy even when treated optimally. and 
required liver transplantation as a last resort. 
Liver transplantation has been attempted on pa-
tients with urea cycle enzyme abnormalities, includ-
ing OTe deficiency. because the liver is responsible 
for producing urea cycle enzymes. In the reported 
casesJ•S•7.8 and our two cases, serum ammonia levels 
decreased promptly after transplantation and then 
serum amino acid profile and urinary orotic acid 
returned to normal range. Our patients emerged 
unscathed neurologically, in contrast to several re-
ported patients who were left impaired despite com-
plete metabolic correction.J•M 
According to Msall et al.1U the most important 
prognostic factor. because it is correlated to brain 
damage and impairment of intellectual function. is 
the duration of neonatal hyperammonemic coma. 
Consequently. early diagnosis and aggressive manage-
ment are the keys to nervous system protection. 
Recently. the prenatal diagnosis of OTe deficiency 
using chorionic villus sampling has become avail-
able2•11 and may facilitate more effective early treat-
ment, particularly of homozygous male patients with 
this disorder in their family histories. It is important 
in all cases to avoid catabolic stress such as dehydra-
tion. malnutrition. or infection. Liver transplantation 
may be indicated in the neonatal period. and al-
though this may be technically difficult. the risks of 
proceeding in expert hands arc less than those of 
irreversible brain damage. 
In conclusion. for patients with OTC deficiency 
who have hyperammonemic encephalopathy. ortho-
topic liver transplantation is an appropriate treat-
ment. In addition to early attempt of transplantation. 
aggressive management of pretransplantation hyper-
ammonemia. especially in the neonatal period. and 
avoidance of catabolic stresses are important for 
preventing neurological damage. 
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